Corpus overview


MeSH Disease

Disease (1)

Cough (1)

Fever (1)

Infections (1)

Hypoxia (1)

Human Phenotype


    displaying 1 - 1 records in total 1
    records per page

    Evidence for structural protein damage and membrane lipid remodeling in red blood SERO cells from COVID-19 patients

    Authors: Tiffany Thomas; Davide Stefanoni; Monika Dzieciatkowska; Aaron Issaian; Travis Nemkov; Ryan C Hill; Richard O Francis; Krystalyn E Hudson; Paul W Buehler; James C Zimring; Eldad A Hod; Kirk C Hansen; Steven L Spitalnik; Angelo D'Alessandro

    doi:10.1101/2020.06.29.20142703 Date: 2020-06-30 Source: medRxiv

    The SARS-CoV-2 beta coronavirus is the etiological driver of COVID-19 disease MESHD, which is primarily characterized by shortness of breath, persistent dry cough MESHD cough HP, and fever MESHD fever HP. Because they transport oxygen, red blood SERO cells (RBCs) may play a role in the severity of hypoxemia HP in COVID-19 patients. The present study combines state-of-the-art metabolomics, proteomics, and lipidomics approaches to investigate the impact of COVID-19 on RBCs from 23 healthy subjects and 29 molecularly-diagnosed COVID-19 patients. RBCs from COVID-19 patients had increased levels of glycolytic intermediates, accompanied by oxidation and fragmentation of ankyrin, spectrin beta, and the N-terminal cytosolic domain of band 3 (AE1). Significantly altered lipid metabolism was also observed, especially short and medium chain saturated fatty acids, acyl-carnitines, and sphingolipids. Nonetheless, there were no alterations of clinical hematological parameters, such as RBC count, hematocrit, and mean corpuscular hemoglobin concentration, with only minor increases in mean corpuscular volume HP. Taken together, these results suggest a significant impact of SARS-CoV-2 infection MESHD on RBC structural membrane homeostasis at the protein and lipid levels. Increases in RBC glycolytic metabolites are consistent with a theoretically improved capacity of hemoglobin to off-load oxygen as a function of allosteric modulation by high-energy phosphate compounds, perhaps to counteract COVID-19-induced hypoxia MESHD. Conversely, because the N-terminus of AE1 stabilizes deoxyhemoglobin and finely tunes oxygen off-loading, RBCs from COVID-19 patients may be incapable of responding to environmental variations in hemoglobin oxygen saturation when traveling TRANS from the lungs to peripheral capillaries and, as such, may have a compromised capacity to transport and deliver oxygen.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).



MeSH Disease
Human Phenotype

Export subcorpus as Endnote

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.